Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Active substance factsheet - Last updated: 05/09/2023
1,2-benzisothiazol-3(2H)-one (BIT)
Evaluating competent authority:
Spain
Assessment outcome:
In progress
Conclusion date:
Assessment Report
DocI_public.pdf (en) (10/05/2022)
Study summary
DocIIIA_PT13_Troy_public.pdf (en) (10/05/2022)
DocIIIA_PT13_1-6_EBITTF_public.pdf (en) (10/05/2022)
DocIIIA_PT13_1-6_LANXESS_public.pdf (en) (10/05/2022)
DocIIIA_Acute_Tox_Inhalation_EBITTF_public.pdf (en) (10/05/2022)
DocIIIA_PT13_1-6_N&B_public.pdf (en) (10/05/2022)
DocIIIA_PT13_7-9_LANXESS_public.pdf (en) (10/05/2022)
DocIIIA_PT13_7-9_N&B_public.pdf (en) (10/05/2022)
DocIIIA_PT13_7-9_EBITTF.pdf (en) (10/05/2022)
BPC opinions
BIT_PT_13_Final_BPC_Opinion.pdf (en) (05/11/2021)
Evaluating competent authority:
Spain
Assessment outcome:
In progress
Conclusion date:
BPC opinions
BIT_PT_13_Final_BPC_Opinion.pdf (en) (05/11/2021)
Evaluating competent authority:
Spain
Assessment outcome:
In progress
Conclusion date:
BPC opinions
BIT_PT_13_Final_BPC_Opinion.pdf (en) (05/11/2021)
Evaluating competent authority:
Spain
Assessment outcome:
In progress
Conclusion date:
Assessment Report
DocI public.pdf (en) (11/04/2022)
Study summary
DocIIIA PT13 7-9 LANXESS public.pdf (en) (11/04/2022)
DocIIIA PT13 1-6 N&B public.pdf (en) (11/04/2022)
DocIIIA Acute Tox Inhalation EBITTF public.pdf (en) (11/04/2022)
DocIIIA PT13 7-9 EBITTF.pdf (en) (11/04/2022)
DocIIIA PT13 1-6 EBITTF public.pdf (en) (11/04/2022)
DocIIIA PT13 1-6 LANXESS public.pdf (en) (11/04/2022)
DocIIIA PT13 7-9 N&B public.pdf (en) (11/04/2022)
DocIIIA PT13 Troy public.pdf (en) (11/04/2022)
BPC opinions
BIT_PT_13_Final_BPC_Opinion.pdf (en) (05/11/2021)